SCAG NASDAQ Week ended 07 Aug 2026

Weekly Investor Report

Scage Future American Depositary Shares · Industrials · Farm & Heavy Construction Machinery

Open interactive chart View report data
Latest close 0.36 USD
14.1% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -66.3% below the Trend Line and sits at 1.8% of its 52-week range. The latest completed week returned 14.1%, after a -15.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.

Setup score 17 out of 100
Latest Close 0.36 USD 7 Aug 2026
1W Return 14.1% latest completed week
4W Return -15.1% short-term follow-through
12W Return -49.7% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 0.0x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 27.39% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 14.1% Latest completed week; four-week move -15.1%. Indicator stack 0/82 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 27.39% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 29 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -66.3% below the Trend Line and sits at 1.8% of its 52-week range. The latest completed week returned 14.1%, after a -15.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.0x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0712-week average 0.05

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.07Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -15.1% over four weeks, -49.7% over 12 weeks, and -90.5% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W14.1%
4W-15.1%
12W-49.7%
26W-81.7%
52W-90.5%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.79Latest activity-pressure read.
Pressure change217.3%Four-week change in activity pressure.
Leadership-82.45Latest relative-leadership reading.
RS change0.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 30 Jun 2025 Field coverage 76% Model confidence 39%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength40/100Blend of value, momentum, and quality. Underlying universe rank 61; rank 1 is best.
Value45/100Relative valuation strength. Underlying universe rank 56; rank 1 is best.
Quality43/100Profitability and accounting quality. Underlying universe rank 58; rank 1 is best.
Momentum45/100Medium-term price momentum. Underlying universe rank 56; rank 1 is best.
Growth45/100Revenue and earnings growth. Underlying universe rank 56; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
2.4x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-1.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-6.4%
Gross profit retained from each unit of revenue.
Operating margin
-14.6%
Operating profit retained from revenue.
Free-cash-flow margin
-7.9%
Free cash flow generated from revenue.
Return on invested capital
-12.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
82.0%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-75.5%
Net share repurchases relative to market value.
Shareholder yield
-75.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-69.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 29 relevant articles.

2 positive · 20 neutral · 7 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-94.4%Distance below the 52-week high.
13-week volatility30.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2617 weeks finished lower.
Best week+74.6%Week of 5 Jun.
Worst week-54.6%Week of 12 Jun.
Latest week+14.1%Week of 7 Aug.

Shape of recent returns

Strong gains7
Modest gains2
Flat weeks0
Modest losses4
Sharp losses13
Recent vol30.2%13-week weekly-return volatility.
Base vol19.6%52-week weekly-return volatility.
Up/down split16/36Count of positive and negative weeks in the 52-week window.
Average skew18.9% / -12.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape21/100

Trend, activity pressure, participation, and risk combine to a 21/100 tape read.

 Indicator analysis22/100

Latest 12-week confirmation: trend 0/12, activity pressure 7/12, relative leadership 0/12.

Activity pressure 0.07; No reversal markers Next-Week ExpectancyNegative 27.39%

Next-week expectancy is negative with a 27.39% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors42/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 99 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 29 relevant articles.

Price to earnings forward of Scage Future – NASDAQ:SCAG Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20260.36 USD14.1%1.08 USD2.32 USD0.79-82.45547.5KOff
31 Jul 20260.32 USD-6.1%1.16 USD2.35 USD0.68-84.481.4MOff
24 Jul 20260.34 USD11.8%1.21 USD2.39 USD0.53-84.16961.5KOff
17 Jul 20260.30 USD-29.1%1.27 USD2.43 USD0.45-86.741.4MOff
10 Jul 20260.43 USD16.2%1.34 USD2.47 USD0.25-82.944.5MOff
3 Jul 20260.37 USD-18.6%1.42 USD2.50 USD0.05-86.0813.5MOff
26 Jun 20260.45 USD20.9%1.47 USD2.54 USD0.08-83.45136.5MOff
19 Jun 20260.38 USD-1.8%1.52 USD2.58 USD-0.18-88.461.3MOff
12 Jun 20260.38 USD-54.6%1.56 USD2.63 USD-0.25-27.9MOff
5 Jun 20260.84 USD74.6%1.61 USD2.67 USD-0.37-92.8MOff
29 May 20260.48 USD-2.9%1.64 USD2.71 USD-0.63-403.1KOff
22 May 20260.50 USD-31.4%1.70 USD2.76 USD-0.63-162.5KOff
15 May 20260.72 USD-10.5%1.77 USD2.80 USD-0.59-44.5KOff
8 May 20260.81 USD-10.2%1.82 USD2.85 USD-0.52-272.8KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context